It notes that currently the EU and Switzerland are the only jurisdictions ‘where nano-specific provisions have been incorporated in legislation.’ Other regions are relying on a more implicit approach – principally derived from the evolution of guidance prepared by industry.
These differing philosophies mean there is the danger of a divergence between the regulatory structures that are developing inside and outside of Europe.
The JRC goes on to say that the rising number of nanotechnologies reaching the market means it is ‘increasingly important to have regulatory frameworks that properly address and specifically manage the potential risks of nanotechnology.
‘Collaboration among countries around the world is required in order to exchange information, and to ensure a high level of protection for humans and the environment, while not hampering the development of new beneficial products and their global marketing,’ it concludes.
The survey was published on 16 June in the journal Regulatory Toxicology and Pharmacology.
This article comes from Food Contact World, which provides exclusive news and analysis on developments in digital print trends, markets, and technologies.